Skin toxicities of targeted therapies

Eur J Cancer. 2009 Sep:45 Suppl 1:295-308. doi: 10.1016/S0959-8049(09)70044-9.

Authors

Siegfried Segaert¹, Gabriela Chiritescu, Liesbeth Lemmens, Kristien Dumon, Eric Van Cutsem, Sabine Tejpar

Affiliation

¹ Department of Dermatology, University Hospital Gasthuisberg, Leuven, Belgium.

PMID: 19775626
DOI: 10.1016/S0959-8049(09)70044-9

No abstract available

MeSH terms

Antineoplastic Agents / adverse effects*
Clinical Trials as Topic
Disease Progression
Disease-Free Survival
Drug Eruptions / classification
Drug Eruptions / etiology*
Drug Eruptions / therapy
Enzyme Inhibitors / adverse effects
ErbB Receptors / antagonists & inhibitors*
Humans
Neoplasms / drug therapy*
Phosphotransferases / antagonists & inhibitors
Telangiectasis / chemically induced
Terminology as Topic
Treatment Outcome

Substances

Antineoplastic Agents
Enzyme Inhibitors
Phosphotransferases
ErbB Receptors